stockrowErasca, Inc. (ERAS) vs Edgewise Therapeutics, Inc. (EWTX)
- Erasca, Inc. ERAS 14.34 +8.06%
- Edgewise Therapeutics, Inc. EWTX 44.89 +15.49%
Erasca, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Erasca, Inc. and Edgewise Therapeutics, Inc. are of similar size ($4.6B and $4.2B). Erasca, Inc. has negative trailing earnings, so its P/E is not meaningful; Edgewise Therapeutics, Inc. trades at 4.9×. Across the 9 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Erasca, Inc. on 2.
Valuation
Profitability
| Metric | ERAS | EWTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (78.25%) | 92.15% | (51.96%) |
| Return on assets | (65.25%) | 85.43% | (46.06%) |
| Return on invested capital | (203.13%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack